Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - COST OF REVENUE
Cost of Revenue REGN - Regeneron Pharmaceuticals, Inc.
1.97 B
LAST VALUE
12.38%
2 YEAR CAGR
20.30%
5 YEAR CAGR
25.39%
10 YEAR CAGR